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When adenosine binds to plasma-membrane receptors on a variety of cell types in 
the kidney, it stimulates functional responses that span the entire spectrum of renal 
cellular physiology, including alterations in hemodynamics, hormone and neuro-
transmitter release, and tubular reabsorption (Table 1). This array of diverse 
responses appears to represent a means by which the kidney and its constituent cell 
types can regulate the metabolic demand such that it is maintained at an appropriate 
Ievel for the prevailing metabolic supply. With the increased recognition of this wide 
array of renal cellular actions, and the continuing development of relatively specific 
adenosine receptor agonist and antagonist ligands, investigators have undertaken 
the task of assigning the different renal actions of adenosine to the known adenosine 
receptor types, by comparison of relative agonist and antagonist potencies. lt is ap-
parent from the inspection of a Iist of the renal actions of adenosine that not only 
does adenosine control a variety of functions, but appears to have a 'dual-control' 
over many aspects of renal function mediated by separate receptors. 
With the exception of their ability to respond to adenosine and adenosine analogs, 
nothing as yet has been described that distinguishes adenosine receptors from the 
wide variety of receptors that modify adenylate cyclase activity and are therefore 
likely members of a large class of hormone receptors that, like the visual pigment 
rhodopsin, are coupled to their intracellular effector systems by guanine nucleotide 
binding proteins. In some systems, however, it has been impossible to correlate 
physiological responses to adenosine with changes in Ievels of cAMP, and therefore 
it has been proposed that adenosine may be coupled to other signal transduction 
systems as well. In the kidney, several of the actions of adenosine associated with 
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activation of the A1 receptor (i.e. vasoconstriction, renin release inhibition, and in-
hibition of neurotransmitter release) are effects that have been proposed to be 
mediated by changes in cytosolic calcium [ 11. 
Adenosine receptor activation in rabbit collecöng tubule cells 
As a nephron segment that regulates water and sodium reabsorption in response to 
the circulating Ievels of vasopressin and aldosterone, the mammalian collecting 
tubule plays an important role in the regulation of extracellular fluid volume and 
composition. In conjunction with circulating hormonal effectors, locally produced 
factors are known to modulate function in this terminal nephron segment. To in-
vestigate the possibility that adenosine receptor activation results in altered collec-
ting tubule function, we isolated highly purified populations of collecting tubule 
cells from rabbit renal cortex using a monoclonal antibody (lgG3-rct 30) as an im-
munoaffinity reagent [2]. A clonal cell line (RCCT -28A) was established from 
primary cultures of purified collecting tubule cells, by infection with an SV-
40/adenovirus-12 hybrid~]. Measurement of cyclic AMP production in response 
to adenosine receptor agotiist-ligands revealed that adenylate cyclase in these cells 
is coupled to both A 1 and A2 adenosine receptors [2]. In addition, measurements 
TABLE 1 
Renal actions of adenosine 
Effect 
Hemodynamic (~ GFR) 
Vasoconstriction (preglomerular) 
Vasodilation (postglomerular) 
Hormonal/neurotransmitter 
Renin release 
Inhibition 
Stimulation 
Erythropoietin 
Inhibition 
Stimulation 
Adrenergic transmission 
Inhibition (presynaptic) 
Tubular 
Collecting Tubule 
i hydraulic conductivity 
~ cyclic AMP 
Receptor 
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of cytosolic free calcium [4] and inositol phosphate production [3] by the 28A cells 
revealed that adenosine activation of a pertussis toxin-sensitive pathway resulted in 
the activation of phospholipase C (Figs. 1 and 2). This response was inhibited by 
the adenosine A 1 receptor antagonist, 8-cyclopentyl-1 ,3-dipropylxanthine (DPCPX) (Fig. 3 and 4). In addition, the elevation of cytosolic free calcium by 
adenosine agonists shows stereoselectivity for the enantiomers of PIA. Despite 
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Fig. 1. Changes in cytosolic free calcium of RCCT-28A cells in response to adenosine analogs S' -N-
ethylcarboxamidoadenosine (NECA) and .tV-cyclohexyladenosine (CHA), presented as percent increase 
in calcium from control. loset: representative fluorescent tracing of response of 28A cells to CHA (0.1 
and 10 p.M). Presented as ratio of fluorescence at excitation wavelength of 340 nm to fluorescence at ex-
citation wavelength of 380 nm. 
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Fig. 2. Effect of penussis toxin on responses to adenosine analogs, CHA and NECA. RCCT -28A cells 
were pretreated with and without pertussis toxin (PT) for 12 h with 1 "g/ml toxin before measurements; 
presented as percent increase from control. See Fig. 1 for definitions of abbreviations. 
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numerous similarities between the adenosine A 1 receptor-induced decrease in cyclic 
AMP production, a fundamental difference is the similarity in the potency of 5 '-
substituted adenosine analogs as compared to l\f>-substituted analogs in the 
receptor-mediated increase in phospholipase C activity (Figs. 1 and 2; Table 2). 
The presence of two different mechanisms associated with the adenosine A 1 
receptor raises several important questions. The first and most obvious is whether 
two classes of A 1 receptors exist. One possibility is that both the inhibition of 
adenylate cyclase and the acceleration of inositol polyphosphate production are pro-
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Fig. 3. Effect of A 1 adenosine receptor antagonist 8-cyclopentyl-1 ,3-dipropylxanthine (CPX) on in-
crease in phosphoinositide turnover produced by NECA and CHA. See Fig. 1 for definitions of abbrevia-
tions. 
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Fig. 4. Effect of Aa adenosine receptor antagonist 8-cyclopentyl-1 ,3-dipropylxanthine (CPX) on increase 
in cytosolic free calcium by NECA and CHA. See Fig. 1 for definitions of abbreviations. 
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TABLE 2 
Comparison of A1 and 'APLc' receptor activation in rabbit cortical collecting tubule cells 
ECso R-PIA/NECA R-PIA/S-PIA DPCPX Pertussis T 
(nM) sensitive 
At 10 R-PIA > NECA R-PIA > > S-PIA + + 
'APLC, 500 R-PIA = NECA R-PIA > > S-PIA + + 
voked by a single receptor population via divergent coupling mechanisms. Alter-
natively, each response may be evoked by independent adenosine receptor popula-
tions. 
Radioligand binding analysis of adenosine A 1 receptors in 28A cells 
To determine whether a single population of A 1 receptors is coupled to divergent 
signaling pathways, we have measured radioligand binding of [3H]DPCPX to 
plasma membranes from rabbit renal medulla and the RCCT-28A cells (28A cells). 
Saturation binding of [3H]DPCPX in 28A membranes (Fig. 5), analyzed by non-
linear curve fitting, gave a one-site model with an apparent K 0 value of 1.4 nM and 
a maximum number of binding sites (BMAX value) of 64 fmol/rng protein. Scat-
chard analysis of the saturation curve gave a linear plot, indicating the presence of 
a homogeneous population of binding sites. The non-specific binding was 20- 300Jo 
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Fig. 5. Saturation binding of eH]DPCPX to RCCT-28A cell membranes. Data are given as specific 
(closed circles) and non-specific binding (open circles). Theinsetshows the Scatchard plot from the data. 
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of the total at the K 0 , and saturation of specific binding was reached with 2 nM 
[3H]DPCPX. 
Competition of several agonists for the [3H]DPCPX binding was measured to 
confirm that [3H]DPCPX binds to the A 1 receptor. Competition of adenosine 
agonists for [3H]DPCPX binding resulted in biphasic displacement curves (Table 
3), indicating the presence of two affinity states for the agonists, with approximately 
one-half of the binding sites being in the high-affinity state and the other half in the 
Iow-affinity state. The Ki values for the various adenosine receptor agonists exhibit 
the typical pharmacological profile for A 1 receptors and the marked stereoselectivi-
ty for the PIA enantiomers. 
Agonist binding was further characterized by measuring the competition of R-
PIA for [3H]DPCPX binding in the presence and absence of GTP (100 p.M). In the 
absence of GTP the competition of [3H]DPCPX by R-PIA resulted in a biphasic 
displacement curve with an apparent K 0 value of 0.5 nM and BMAX value of 
16.1 pmol/mg protein for the high-affinity state and a low-affinity K 0 value of 
10.5 nM and BMAX value of 20.2 fmol/mg protein. When the competition experi-
mentwas carried out in the presence of 100 p,M GTP, a monophasic curve was ob-
tained, indicating a single affinity state with a K0 value of 17.7 nM and a BMAX 
value of 54.1 fmol/mg protein. Control binding (IOOOJo) increased from 36 .. 3 to 
54.1 fmol/mg protein with the addition of 100 ~tM GTP. 
These binding data confirm the previously reported functional data, that cells of 
the cortical collecting tubule have adenosine A 1 receptors coupled through GTP-
binding proteins. Furthermore, these binding data fail to provide support for the 
hypothesis that the inhibition of adenylate cyclase and the stimulation of 
phospholipase C are coupled to two sub-populations of the A 1 receptor, although 
it is recognized that this conclusion may be a function of the inability of currently 
available ligands to differentiate between the A 1 receptor subtypes. Furthermore, a 
final caveat to the above conclusion is that binding analysis can only reveal the 
nature of the binding domain of the receptor. lt is possible that the Iigand binding 
domain of the two receptor populations is the same, but the receptors are structural-
ly different, for example in the G-protein coupling domains, allowing for separate 
or non-promiscuous signal activation. 
TADLE 3 
Pharmacological profile of eHJDPCPX binding to RCCI' -28A rnembranes 
K~ (nM) K~ (nM) 
R-PIA 0.5 7.0 
NECA 1.8 47 
S-PIA 3.1 275 
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In conclusion, in the absence of evidence of sub-populations of the A 1 receptor, 
it appears that activation of a single A 1 receptor population, at least as defined by 
radiolabeled Iigand binding analysis, results in the inhibition of adenylate cyclase 
and the activation of phospholipase C. Although GTP-binding proteins link recep-
tor occupancy to changes in both inhibition of cyclase and the acceleration of in-
ositol phosphate production, the identity of the GTP-binding proteins involved in 
vivo and the mechanisms arenot certain. Finally, it remains tobe determined which 
of the possible signaling events induced by occupancy of receptors linked to the in-
hibition of adenylate cyclase and/ or phospholipase C are causal in mediating a given 
physiological event, which are permissive, and which are without any functional 
consequence in a given setting. 
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Discussion 
J. Linden: Have you tried yet to determine if adenosine can activate phospholipase C in broken or 
permeabilized cells? 
W .S. Spielman: It's a good idea but we haven't as yet tried it. 
I.L.O. Baxton: Not all would agree that a Gi protein couples receptors to regulation of phosphoinositide 
turnover in noncirculating (non-blood-borne cells) tissues. I wonder if the effect of a pertussis toxin sen-
sitive Stimulation of PI-turnover is the result of the viral transfection you have used to immortalize your 
cell line, or, conversely, that the effect is due to crosstalk produced by high agonist concentration that 
allows Gi-protein sub-units to influence another 0-protein-mediated pathway? That is, that Gia or ß'Y 
could influence the activity of a Gp-GTP binding protein? 
W .S. Spielman: As for the possibility that the pertussis toxin sensitivity is a function of the viral transfor-
mation of the cells, we are sure this is not the explanation as we see the sameresponsein freshly isolated 
cells and cells in primary culture. In regard to the possibility that liberated ß-y subunits from some other 
Gi-protein is responsible for the effect on phospholipase C activity is an interesting idea, but it seems 
to us that if true that would inhibit, rather than stimuJate PLC activity. 
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B.B. Fredholm: Some time ago Dr. Häggblad and I reported that in the rat vas deferens adenosine had 
little effect by itself on IP formation whereas it did enhance the IP formation induced by an a 1-agonist. 
Is it possible that also in your system the effect of adenosine on Pl-turnover is an indirect rather than 
a direct consequence of adenosine receptor activation? An effect due to interaction with a parallel signal 
transduction pathway may also explain the unusual dose-response relationship. 
S.J. Mustafa: Have you measured the changes in cyclic nucleotides with both NECA and R-PIA. This 
might help to understand the type of At receptor and its coupling to the second messenger systems. 
W.S. Spielman: Yes, we have determined full concentration-response curves for CHA, R-PIA and 
NECA on cyclic AMP. What we see is a pattern of response that is entirely in keeping with the concept 
of a classical high-affinity At and low-affinity A 2 receptor system coupled to the inhibition and stimula-
tion of adenylate cyclase respectively. 
L. Belardinelli: Is the magnitude of the PTX inhibition of adenosine-induced stimulation of PLC and 
inhibition of cAMP production the same? 
W.S. Spielman: I can only say that when we treat our cells with 1 #A-g/ml pertussis toxin for 12 h, both 
responses are completely inhibited. Perhaps if we used a series of lower concentration of the toxin we 
could uncover a difference between the sensitivity of the two systems. 
D.M.F. Cooper: (1) How does the _.c\ 1 Stimulation of [Ca2 + ]i compare in magnitude with that elicited 
by e.g. bradykinin. (2) Does cAMP influence the A 1 effect on [Ca2 + )i - this question is raised to con-
sider the possibility that you are actually getting an A 2 stimulation of [Ca2 + ]i, based on your low poten-
cy of PIA in mediating the effect: NECA being relatively impotent at A 1 receptors might then be 
equipotent with PIA at eliciting the effect, given that PIA concentration would have tobe increased to 
Ievels that overcame the inhibition of cAMP. 
W.S. Spielman: (1) The maximal increase in cytosol Ca2 + in response to adenosine agonist ligands is ap-
proximately lOOOJo. This is substantially less than we observe with bradykinin. (2) This is an interesting 
possibility that we haven't investigated fully, but I don't think it is the explanation because recall that 
pertussis toxin pretreatment inhibits the mobilization of cytosolic calcium but actually enhanced the abili-
ty of the NECA and other agonist to simulate cyclic AMP production, presumably by eliminating the 
inhibitory input. 
J.W. Daly: Is the potency of 8-cyclopentyl-1,3-dipropylxanthine versus A 1-receptor-mediated inhibition 
of cyclic AMP formation similar or different from its potency versus 'A1 '-receptor-mediated stimula-
tion of phosphoinositide breakdown in RCCf28A cells? 
W.S. Spielman: I can't tell you off-band the exact IC50 values for DPCPX on the two responses but I 
can say we don't observe any major differences. If differences do exist, they are relatively small. 
